The last reason to buy Iovance stock like there's no tomorrow is that it has a strong balance sheet, which is core to a biotech company's survival in the period before it has significant revenue. In ...
Medigene continually extends and strengthens its patent portfolio with new technologies and expands existing patents into additional jurisdictions. The Company maintains 29 different patent families ...